Achieve Life Sciences ACHV Restricted Cash And Other Assets
Restricted Cash And Other Assets at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept achv:RestrictedCashAndOtherAssets.
The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's restricted cash and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Achieve Life Sciences's restricted cash and other assets?
- Achieve Life Sciences (ACHV) reported restricted cash and other assets of $52K in Q4 2025.
- How has Achieve Life Sciences's restricted cash and other assets changed year-over-year?
- Achieve Life Sciences's restricted cash and other assets increased by 33.3% year-over-year, from $39K to $52K.
- What is the long-term trend for Achieve Life Sciences's restricted cash and other assets?
- Over 4 years (2021 to 2025), Achieve Life Sciences's restricted cash and other assets has grown at a -27.0% compound annual growth rate (CAGR), from $183K to $52K.
- What does restricted cash and other assets mean?
- This represents cash and cash equivalents that are legally restricted from general corporate use, typically held as collateral for long-term obligations or specific contractual requirements. It serves as a measure of liquidity that is unavailable for immediate operational funding or capital expenditures. Investors monitor this to understand the portion of the balance sheet tied up in non-liquid, restricted arrangements.